iThriveMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: Californians and Arizonans who want compounded GLP-1 inside a lab-driven clinic
iThriveMD scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $299/mo ongoing
Tirzepatide
then $399/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
iThriveMD is a longevity and metabolic-health clinic with locations in California and Arizona plus telehealth, offering compounded semaglutide ($299 per 28 days) and tirzepatide ($399 per 28 days) at the same price for every dose, with $100 off the first month. A low-dose tirzepatide microdosing program costs $585 for 12 weeks, and prepaid 3 to 12-month plans lower the rate. Care starts with a free phone consult and is lab-driven, alongside hormones, NAD+, peptides, and IV therapy. All purchases are final.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to iThriveMD
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
iThriveMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Microdosing tirzepatide
- Starting price
- $299/mo (after intro offer) ($199 first month)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Coaching
- Availability
- 2 states
- FDA status
- No FDA warning letter on record
How we scored iThriveMD
Each dimension is scored algorithmically from iThriveMD’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.2/10At $299/mo (after intro offer), iThriveMD runs about 64% above the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $199. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.4/10iThriveMD offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.7/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.9/10iThriveMD operates in a limited 2-state footprint, so check availability first.
Support10%
7.5/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this iThriveMD review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 2 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $299–$399/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with iThriveMD
We walked iThriveMD’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Open a GLP-1 treatment page and review the monthly and prepaid 3, 6, and 12-month prices.
- 2Click Schedule free consultation to open the booking widget for a 15-minute phone consult.
- 3The booking form asks for name, phone, email, and how you heard about them before a time can be booked; we stopped here.
- Prices for every plan length are listed on each medication page before any sign-up.
- Plans are billed every 28 days, not monthly, which adds a 13th charge each year.
- Standard GLP-1 care starts with diagnostic lab work; the microdosing program says no labs or BMI are required.
- The phone number shown changes from page to page, which looks like call tracking.
- All purchases are final, per the Returns policy.
GLP-1 medications iThriveMD offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides iThriveMD offers
Beyond GLP-1s, iThriveMD also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$299 every 28 days, $199 first month. Longer plans per 28 days, paid upfront: 3-mo $269.10, 6-mo $254.15, 12-mo $239.20.
$399 every 28 days, $299 first month. Longer plans per 28 days, paid upfront: 3-mo $299.25, 6-mo $259.35, 12-mo $199.50. Microdose plan: $585 per 12 weeks.
Ready to get started?
Plans and promotions change often, so check iThriveMD's current pricing and active discounts before you decide.
What we like
- Same price at every dose: semaglutide $299 and tirzepatide $399 per 28 days, with $100 off the first month
- Prepaid 3, 6, and 12-month plans lower the rate, down to $199.50 per 28 days for tirzepatide
- Low-dose tirzepatide microdosing program with no labs or BMI requirement
- In-person clinics in California and Arizona plus telehealth, with lab-based care and coaching
- Shows a LegitScript seal and publishes Terms, Privacy, Returns, and Shipping policies
Watch-outs
- Billed every 28 days, so you pay 13 times a year instead of 12
- Pricier than many online-only compounded GLP-1 services
- All purchases are final, and subscription payments are non-refundable
- Only serves patients in California and Arizona
- Shipping cost is listed inconsistently (free 2-day on one page, $9 standard in the policy)
- Compounding pharmacy partner is not named
Is iThriveMD worth it?
What iThriveMD is selling, in one line, is Californians and Arizonans who want compounded GLP-1 inside a lab-driven clinic. New patients start at $199/month for the first month, but the price steps up to $299/month once that window ends, so treat the headline number as an intro offer, not the standing rate. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
Beyond the medication itself, iThriveMD offers a microdosing option and is LegitScript-certified.
How much iThriveMD costs
- Compounded semaglutide starts at $199 for the first month, then $299/month after that, if you go that route.
- Compounded tirzepatide starts at $299 for the first month, then $399/month after that, at that tier.
Because iThriveMD's headline figure is listed as “after intro offer”, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare iThriveMD with the month-to-month prices of the alternatives below instead.
MangoRx (about $299/month) is one of the closest alternatives to weigh iThriveMD against.
Medications: what iThriveMD prescribes
iThriveMD prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who iThriveMD is best for, and who should skip it
A good fit if you…
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
iThriveMD is available in 2 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
iThriveMD's intro price of $199 takes some of the cost out of the first month, but plan around the $299/month standing price, since that is what you pay from then on.
The Bottom Line
iThriveMD scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with iThriveMD?
From $299/mo (after intro offer). See current pricing and start your free consultation.
iThriveMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare iThriveMD vs…
iThriveMD scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
iThriveMD vs Amazon One Medical
Amazon One Medical scores 8.5/10

iThriveMD vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this iThriveMD review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See iThriveMD's current pricing
Plans from $299/mo (after intro offer). Start your free consultation to check eligibility and today's price.